Live Trading News
Shayne Heffernan

Fake News on Sputnik V Covid1 Vaccine Proven Wrong

By Shayne Heffernan4 min read

Moscow savoured its scientific and political win Wednesday after a top medical journal declared the Sputnik V Covid vaccine safe and effective, and said it was working to increase production of the jab abroad.

The Lancet published results on Tuesday showing the homemade Russian vaccine -- named after the Soviet-era satellite -- to be 91.6 percent effective against symptomatic Covid-19 cases.

The shot faced Western criticism last year when it was approved in Russia before large-scale clinical trials.

The development represents a major scientific and political victory for President Vladimir Putin, who has called Sputnik V the world's best vaccine.

The latest results have also allayed some Western concerns over the transparency of the Russian jab and increased hopes for ending the pandemic, as many European nations struggle with rolling out their vaccines.

In a call with reporters Wednesday, Kremlin spokesman Dmitry Peskov said The Lancet article demonstrated the "reliability and effectiveness of the Russian vaccine".

"And besides that, (it) probably also confirmed the justification of the accelerated registration of this vaccine in the Russian Federation," he said, adding that the jab's safety was "proven".

On Wednesday, the banner headline of the pro-Kremlin Izvestia daily's front page celebrated the "successful launch" of the jab.

"Russian 'Sputnik V' has been recognised as the safest vaccine," the newspaper said.

From the first weeks of the pandemic, Putin ordered the country's scientific, political and military apparatus to work in overdrive to develop the world's first Covid vaccine -- even if that meant taking shortcuts.

Russia registered Sputnik V -- a two-dose vaccine using adapted strains of the adenovirus, which causes the common cold -- in August, months before Western competitors and even before large-scale clinical trials.

Its developers later said the vaccine is over 90 percent effective and Russia began inoculating citizens in December.

Sputnik V has been approved in more than 15 countries, including several ex-Soviet republics but also Argentina, Tunisia and Pakistan.

The Russian Direct Investment Fund (RDIF), which helped finance Sputnik V, has said that more than two million people have been inoculated with the jab around the world.

- Boosting production -

Peskov said Russia was working to further boost production of the vaccine in foreign nations.

"The number of countries that register this vaccine at home is increasing every day," he said. "We are very active in responding to enquiries from various countries asking for the supply of this vaccine."

Rather than exporting Sputnik V in bulk, Moscow hopes to develop production partnerships with local factories.

Brazil, India, Kazakhstan and South Korea are currently producing the jab, though not all them have made it available to the public yet.

RDIF applied for registration of Sputnik V in the European Union last month and German Chancellor Angela Merkel has expressed willingness to its use once the jab receives the regulatory nod.

The EU is facing anger over a sluggish start to its mass vaccination campaign and member state Hungary has already registered the Sputnik jab on its own.

While Moscow has aspirations for Sputnik V to increase its geopolitical clout, Peskov emphasised that "priority is given to Russia's domestic needs".

But beyond its capital and largest city Moscow, where Mayor Sergei Sobyanin estimated Saturday that some 300,000 people had already been vaccinated, Russia has struggled with rolling out Sputnik V.

On Tuesday, the governor of the northwestern Leningrad region, surrounding the country's second-largest city Saint Petersburg, said it had used up its first 10,000 vaccine doses and was now waiting for additional supplies.

By Wednesday, Russia had reported 3.9 million coronavirus infections -- the fourth-highest caseload in the world.

Russia faces a population sceptical of getting vaccinated, with recent surveys showing only 38 percent of respondents were prepared to be inoculated against Covid.

Some critics have pointed to the fact that Putin has yet to have the jab.

Peskov dismissed those concerns. "In general the perception of the vaccine is at a good level," he said.

Keep reading
AI slop

AI is the Neat Handwriting of the Illiterate

A model in the hands of someone who has read the filing and walked the plant is a clerk. The same model, speaking for someone who has done neither, is a disguise. On AI slop, phantom citations and factslop, why finish stopped being evidence of work, and the containment layer KXCO built so a machine cannot speak as the institution until a source is attached.

Shayne Heffernan19 min
worthship

Worthship: Do Not Conform to the Age

Worthship is the older English word for worship, and it means to ascribe worth. Bishop Robert Barron preached Romans 12 on 30 August. This essay follows the text into the prison letters, and puts two questions to a graph: do the four readings of that Sunday agree, and was Paul free or in chains when he wrote about despair?

Shayne Heffernan17 min
truth

The Truth in All Its Ugliness Must Survive

A majority vote does not determine the truth. Consensus is a mood, gossip is a sport, and a model will write the pretty version for free. Why the ugly number has to survive, why a record beats a dashboard, and what KXCO was built to keep standing when the room changes its mind.

Shayne Heffernan8 min
Shayne Heffernan

Don't Be the Best, Be the Only: Winning in an AI World

AI is repricing competence downward. What it cannot reproduce is a life. The case for remaining non-fungible, why friction still produces the best ideas, and what it means to build AI systems that keep the human intellect in them.

Shayne Heffernan18 min
Read Live Trading News on Telegram

Every story, signed and delivered.

Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.

Open @KnightsbridgeInsightsNo email required.